Skip to content

Clinical trials

Phase 1/2 Lung Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1/2 Country / region: Taiwan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20161
20173
20192
20201
20211
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AVEO Pharmaceuticals, Inc.1
Bristol-Myers Squibb1
Eli Lilly and Company1
Hoffmann-La Roche1
Incyte Corporation1
Inhibrx Biosciences, Inc1
Merrimack Pharmaceuticals1
Mural Oncology, Inc1
National Taiwan University Hospital1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms13
Carcinoma, Non-Small-Cell Lung12
Neoplasms7
Neoplasms by Site5
Carcinoma4
Head and Neck Neoplasms4
Lung Diseases4
Neoplasms by Histologic Type4
Respiratory Tract Diseases4
Respiratory Tract Neoplasms4

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.